ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02088684
Recruitment Status : Active, not recruiting
First Posted : March 17, 2014
Last Update Posted : February 26, 2018
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 15, 2018
  Estimated Study Completion Date : June 15, 2018